Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.40 | N/A |
| PEG Ratio (TTM) | -4.66 | N/A |
| P/S Ratio (TTM) | 2.25 | N/A |
| P/B Ratio (TTM) | 0.86 | N/A |
| P/FCF Ratio (TTM) | -6.51 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.01 | N/A |
| Price to 5YR AVG FCF Ratio | 12.23 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.60% | N/A |
| ROE (TTM) | 4.82% | N/A |
| Net Profit Margin (TTM) | 12.20% | N/A |
| ROIC 5YR AVG | 8.51% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.25% | 17.54% | 5.91% |
| Revenue | 0.71% | 7.27% | 6.58% |
| Net Income | 3.12% | 16.48% | 5.23% |
| Cash Flow | 368.07% | 14.69% | 3.10% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.11 | N/A |
| Interest Coverage (TTM) | 2.02 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.30 | N/A |
| LTL to 5YR AVG FCF | 1.68 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.61% | N/A |